Rivastigmine [rivastigmin]
- Terms
-
Exelon
rivastigmin tartarát
-
(S)-N-Ethyl-3-((1-dimethyl-amino)ethyl)-N-methylphenylcarbamate
ENA 713
ENA-713
Exelon
Rivastigmine Hydrogen Tartrate
RivastigmineTartrate
SDZ ENA 713
A carbamate-derived reversible CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used for the treatment of DEMENTIA in ALZHEIMER DISEASE and PARKINSON DISEASE.
- DUI
- D000068836 MeSH Browser
- CUI
- M0196402
- CAS
- Carbamic acid, ethylmethyl-, 3-(1-(dimethylamino)ethyl)phenyl ester, (S)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1)
- History note
- 2016 (1992)
- Public note
- 2016; RIVASTIGMINE was indexed under PHENYLCARBAMATES 2004-2015; and under CARBAMATES 1992-2004
Allowable subheadings
- AD
- administration & dosage 7
- AE
- adverse effects 2
- AG
- agonists
- AA
- analogs & derivatives 1
- AN
- analysis 1
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis 1
- CH
- chemistry 1
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics 1
- PD
- pharmacology 7
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 14
- TO
- toxicity
- UR
- urine